Dr. Michael S Lehrer, M.D. Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 501 Gordon Dr, Exton, PA 19341 Phone: 610-594-6660 Fax: 610-594-6810 |
Dr. Charles L Meyers, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 501 Gordon Dr, Exton, PA 19341 Phone: 610-594-6660 Fax: 610-594-6810 |
Dr. Scott Lawrence Gottlieb, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 501 Gordon Dr, Exton, PA 19341 Phone: 610-594-6660 Fax: 610-594-6810 |
Hannah Yaqian Liu, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 80 W Welsh Pool Rd Ste 103n, Exton, PA 19341 Phone: 610-634-8500 Fax: 610-982-1555 |
Dr. Daniel Dvorkin, MD Dermatology Medicare: Medicare Enrolled Practice Location: 319 N Pottstown Pike, Suite 102, Exton, PA 19341 Phone: 215-305-8834 Fax: 610-363-2026 |
Dr. Aerlyn G Dawn, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 501 Gordon Dr, Exton, PA 19341 Phone: 610-594-6660 Fax: 610-594-6810 |
News Archive
The predominant cause of death in cancer patients is metastasis, the formation of secondary tumors in other organs like the brain, liver, and lungs. Cancer cells detach from the original primary tumor and reach a single cell or group of cells in another organ. The cells of the body normally remain in place through adhering to an extracellular substance. However, cancer cells learn how to release themselves from these bonds and invade surrounding tissues, blood, and the lymphatic system.
Two new research studies published in Biological Psychiatry point to progressive abnormalities in brain development that emerge as vulnerable individuals develop schizophrenia.
Identifying a suitable donor for leukemia and lymphoma patients who need bone marrow transplants may be far easier now that results of two clinical trials show transplant results with half-matched bone marrow or umbilical cord blood are comparable to fully matched tissue, thanks in large part to the availability of effective antirejection drugs and special post-transplant chemotherapy.
Researchers at the University of Pittsburgh and their collaborators have been awarded a $5.6 million federal contract to pursue the continued development of an implanted ventricular assist heart pump for infants and small children with congenital or acquired heart disease. The project aims to provide much-needed access to the sophisticated technologies that have saved the lives of older heart failure patients.
› Verified 8 days ago